A new AI-driven framework, MapDiff, enhances inverse protein folding accuracy, accelerating the design of proteins for ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

AstraZeneca has signed a research agreement worth more than $5 billion with Chinese drugmaker CSPC Pharmaceutical Group, the ...

remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...

Automated cell culture systems, guided by imaging and machine learning-driven decision-making, hold significant promise for advancing 3D biology. These technologies can enhance both throughput and ...

A recent study published in Scientific Reports looked at how different cleaning methods affect the physical and visual properties of 3D-printed orthodontic aligners. The researchers tested brushing ...

The automatic recognition of 3D objects with "uncooperative" surfaces is a difficult and slow process. The Fraunhofer IOF has a solution. The Fraunhofer Institute for Applied Optics and Precision ...

The AstraZeneca PLC ADR AZN rose 1.64% to $73.00 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.32% to ...

With the increased interest in 3D biological models, researchers need an imaging platform that can provide high-throughput, high-quality imaging and advanced analytics. This scientific poster ...

Here are some data highlights and executive commentary from the larger companies I follow: AstraZeneca wins big (again) – The blockbuster drug Enhertu from AstraZeneca and Japanese drugmaker ...